CompletedPHASE1, PHASE2NCT00584935
Clinical Trial Evaluating Rituximab in Ocular Cicatricial Pemphigoid
Studying Ocular cicatricial pemphigoid
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University of Alabama at Birmingham
- Principal Investigator
- Craig A Elmets, MDUniversity of Alabama at Birmingham
- Intervention
- Rituximab(drug)
- Enrollment
- 3 enrolled
- Eligibility
- 19 years · All sexes
- Timeline
- 2006 – 2010
Study locations (1)
- University of Alabama at Birmingham, Birmingham, Alabama, United States
Collaborators
Genentech, Inc. · Biogen
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00584935 on ClinicalTrials.gov